Pacific Biosciences of California, Inc. (PACB) Operating cash flow 2016–2025
Pacific Biosciences of California, Inc. (PACB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$111.2MFY2025 · since FY2016: -$67.9M → -$111.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$111.2M | +46.0% |
| FY2024 | -$206.1M | +20.5% |
| FY2023 | -$259.2M | +1.5% |
| FY2022 | -$263.2M | -136.7% |
| FY2021 | -$111.2M | -670.1% |
| FY2020 | $19.5M | +124.9% |
| FY2019 | -$78.3M | -17.9% |
| FY2018 | -$66.4M | +1.6% |
| FY2017 | -$67.5M | +0.6% |
| FY2016 | -$67.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice